Cardiovascular medication in relation to renal function after coronary artery bypass surgery

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4033-4038

  Sartipy, Ulrik ^a,b   Rampell, Erik ^a,b   Carlsson, Axel C ^b   Wändell, Per ^b   Holzmann, Martin J ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CABG; Coronary artery disease; Pharmacoepidemiology; Renal dysfunction; Secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SECONDARY PREVENTION; SEX DIFFERENCE; SWEDEN; ADULT; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECTS; EPIDEMIOLOGY; HEALTH SURVEY; KIDNEY; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SWEDEN; TREATMENT OUTCOME;

EID: 84886315121     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.066     Document Type: Article

References (28)

1. S.I. Hallan, J. Coresh, and B.C. Astor International comparison of the relationship of chronic kidney disease prevalence and ESRD risk J Am Soc Nephrol 17 2006 2275 2284
2. M.J. Holzmann, T. Ivert, and I. Jungner Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and women J Intern Med 267 2010 357 369
3. M.G. Shlipak, M.J. Sarnak, and R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2005 2049 2060
4. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
5. M. Tonelli, P. Muntner, and A. Lloyd Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study Lancet 380 2012 807 814
6. H. Bang, M. Mazumdar, and G. Newman Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience Nephrol Dial Transplant 24 2009 2452 2457
7. K. Szummer, P. Lundman, and S.H. Jacobson Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) Circulation 120 2009 851 858
8. S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 124 2011 2458 2473
9. M.J. Holzmann, S. Ahnve, and N. Hammar Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting J Thorac Cardiovasc Surg 130 2005 746 752
10. G.S. Hillis, B.L. Croal, and K.G. Buchan Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up Circulation 113 2006 1056 1062
11. M.G. Shlipak, P.A. Heidenreich, H. Noguchi, G.M. Chertow, W.S. Browner, and M.B. McClellan Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients Ann Intern Med 137 2002 555 562
12. C.S. Fox, P. Muntner, and A.Y. Chen Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the national cardiovascular data acute coronary treatment and intervention outcomes network registry Circulation 121 2010 357 365
13. T.I. Chang, L. Gao, and T.M. Brown Use of secondary prevention medications among adults with reduced kidney function Clin J Am Soc Nephrol 7 2012 604 611
14. T. Jernberg, M.F. Attebring, and K. Hambraeus The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) Heart 96 2010 1617 1621
15. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
16. J.F. Ludvigsson, P. Otterblad-Olausson, B.U. Pettersson, and A. Ekbom The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research Eur J Epidemiol 24 2009 659 667
17. J.F. Ludvigsson, E. Andersson, and A. Ekbom External review and validation of the Swedish national inpatient register BMC Public Health 11 2011 450
18. B. Wettermark, N. Hammar, and C.M. Fored The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months Pharmacoepidemiol Drug Saf 16 2007 726 735
19. A.C. Carlsson, P. Wändell, K. Sundquist, S.E. Johansson, and J. Sundquist Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007 Eur J Clin Pharmacol 69 2013 245 253
20. G. Zou A modified poisson regression approach to prospective studies with binary data Am J Epidemiol 159 2004 702 706
21. R.J. Little, R. D'Agostino, and M.L. Cohen The prevention and treatment of missing data in clinical trials N Engl J Med 367 2012 1355 1360
22. A.S. Levey, and J. Coresh Chronic kidney disease Lancet 379 2012 165 180
23. P. Muntner, L.L. Hamm, J.W. Kusek, J. Chen, P.K. Whelton, and J. He The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
24. A. Levin, C.R. Thompson, and J. Ethier Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 1999 125 134
25. M.J. Holzmann, I. Jungner, and G. Walldius Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease Ann Med 44 2012 262 270
26. W.C. Winkelmayer, R. Levin, and S. Setoguchi Associations of kidney function with cardiovascular medication use after myocardial infarction Clin J Am Soc Nephrol 3 2008 1415 1422
27. National Kidney Foundation K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 43 2004 S1 S290
28. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497